ASTH - Company ID 0001083446
The table below shows Astrana Health, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $773.91M | $687.18M |
| Cost of revenue | - | - | - | - | $596.14M | $539.21M |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Astrana Health, Inc. reported annual revenue of $3.18B for fiscal year 2025. That is up 56.4% from $2.03B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $57.43M (FY 2017) to $3.18B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $217.26M |
| $154.11M |
| $112.60M |
| $77.67M |
| $62.08M |
| $49.12M |
| Operating income | $78.53M | $89.35M | $84.61M | $104.27M | $98.18M | $80.50M |
| Income tax | $15.53M | $30.89M | $31.99M | $40.88M | $31.69M | $56.34M |
| Net income | $24.00M | $50.00M | $58.00M | $46.00M | $46.00M | $37.69M |
| EPS (diluted) | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 |